Ardsley Advisory Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bioceres Crop Solutions
BIOX
|
+$21M |
| 2 |
First Solar
FSLR
|
+$14.5M |
| 3 |
SentinelOne
S
|
+$8.86M |
| 4 |
Flex
FLEX
|
+$7.72M |
| 5 |
Stem
STEM
|
+$6.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MBII
Marrone Bio Innovations, Inc.
MBII
|
+$21.3M |
| 2 |
STKL
SunOpta
STKL
|
+$20.8M |
| 3 |
SolarEdge
SEDG
|
+$13.7M |
| 4 |
Wolfspeed
WOLF
|
+$9.1M |
| 5 |
Enovix
ENVX
|
+$7.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.23% |
| 2 | Healthcare | 15.62% |
| 3 | Utilities | 8.11% |
| 4 | Materials | 6.26% |
| 5 | Consumer Staples | 5.46% |
Similar funds
Ardsley Advisory Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Ardsley Advisory Partners held 164 positions worth $447M, down 27% from $608M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Ardsley Advisory Partners withdrew a net $195M in Q3 2022, closing 61 positions and reducing 35 holdings. Its most notable exit was Marrone Bio Innovations, Inc., an estimated $21.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 25% a quarter earlier, followed by Healthcare and Utilities.
Against the trend, Ardsley Advisory Partners opened a new position in Bioceres Crop Solutions worth $22.3M.
- Ardsley Advisory Partners's largest Q3 2022 buy was Bioceres Crop Solutions: 1,710,618 shares worth $22.3M.
- Ardsley Advisory Partners added most to First Solar in Q3 2022, an estimated $14.5M increase.
- Ardsley Advisory Partners's biggest Q3 2022 reduction was SunOpta, cutting an estimated $20.8M.
- Ardsley Advisory Partners fully exited Marrone Bio Innovations, Inc. in Q3 2022, selling an estimated $21.3M.
- Ardsley Advisory Partners's ten largest holdings make up 42% of its $447M portfolio in Q3 2022.
- Ardsley Advisory Partners opened 40 new positions and closed 61 in Q3 2022.
- Ardsley Advisory Partners's portfolio value fell 27% quarter-over-quarter to $447M.
Based on Ardsley Advisory Partners's 13F filing for Q3 2022, filed 14 Nov 2022.